Medical Tourism Market By Treatment Type (Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 28, 2016

Key Findings


‘Medical tourism’ is defined as the term used for travelling of patients from their home country to different destinations for the sole purpose of treatment that may also include an extended holiday for rest and pleasure. Rising healthcare costs in developed countries along with the availability of high quality medical services available at lower prices in various developing nations has primarily propelled the expansion of the medical tourism industry, globally. Moreover, increasing elderly population coupled with growing number of uninsured population has further boosted the market growth. Nowadays, patients are travelling abroad not only to get cosmetic surgeries with a quick recovery, but also for more sophisticated cardiovascular surgeries. Many countries are planning to leverage medical tourism as a strategy to drive the growth in their healthcare services and tourism industry. By reassuring its presence in the medical tourism market, a country can trigger its economic growth and create various new employment opportunities. Subsequently, the medical tourism industry is increasingly expanding and is expected to have a significant growth in the near future. The global medical tourism industry was estimated to worth around $12.5 billion in 2015, and is anticipated to grow to $37 billion by 2022, growing at a strong CAGR of 17.9% during the forecast period.


Medical tourism is a direct result in globalization of healthcare industry. According to the Medical Tourism Association, a global non-profit organization, it was calculated that approximately 2.2 million Americans travelled to various other destinations in 2014 to get medical services, and this number is projected to get high growth in the near future. Rising number of uninsured residents in under developed countries and increased demand for cosmetic surgery is further expected to fuel the market growth. There is abrewing opportunity for Asian and Middle Eastern countries that are catering to the healthcare requirements as of developed countries like the U.S, Canada, and European countries. Factors like medical specializations, portability of health insurance, geographic proximity, and reputation of the country are some of the key reasons that forces the patient to move to another destinations for medical purposes. However, factors such as problem in follow-up care, unwanted medical malpractices, and others could restrain the growth of this market.


Market Segment Insight


The global medical tourism market is basically segmented on the basis of type of treatment. The reason behind categorizing the market on the basis of type of treatment is, the cost price difference for treatments as well as the availability of treatments in various regions. Also, the difference in wait time for the patients to get the treatment differs a lot in the regions and that is why medical treatment is getting promoted all around world. Type of treatment is categorized as:cardiovascular treatment;orthopedic treatment;neurological treatment;cancer treatment;fertility treatment; and,other general treatments. Diseases like cardiovascular cancer and neurological cases, are expensive and the availability of these treatment is the major concern. That is the reason due to which patients are traveling to other destinations to get affordable and effective solution for their problems.

 

Regional Insight


Geographically,the major markets regionswhich areactively working upon for medical tourism consist of Asia Pacific, Eastern Europe, Western Europe, North America, and South America. Top destinations famous in medical tourism are Costa Rica, India, Israel, Malaysia, Mexico, Singapore, South Korea, Taiwan, Thailand, Turkey, and the United States. The increasing popularity of medical tourism has also proved beneficial for the tourism industry. For example, Thailand in the Asia Pacific region is a very popular country for medical as well as regular tourism. Moreover, government initiatives and increasing investments in the regions are driving additional growth in the market.


Competitive Insights


Some of the significant players in medical tourism market include Apollo Hospitals Enterprise Ltd.; Bumrungrad International Hospital; Asian Heart Institute; and, many others.The strategies used by these companies includesproviding exceptional surgical options; optimum comfort level to the patients;advanced clinical information; publishingvarious educational articles; expertise and specialist medical services; best in quality and safety services; provision of medical treatments in most affordable prices; and, creation of strong brand equity to gain competitive advantages. These major key player offers new and advanced medical treatment for gastrointestinal diseases, In vitro fertilization, orthopedics, kidney diseases, cancers, interventional cardiology, bio-compatible artificial joints, plastic surgery, pulmonology, joint replacement, and many other treatments. However, dental care, cardiology general surgery, urology, women’s health care services, neurology, organ transplants, plastic surgery, and orthopedic surgery are very widely offered services in medical tourism. These companies are also adopting strategies such as collaborations, affiliations, and joint ventures for expanding their business. For example, in October 2014,Bumrungrad International Hospital, Bangkok, and IBM Watson entered in a partnership to improvise the quality of cancer care treatment.

CHAP 1. METHODOLOGY & SCOPE 1
1.1. RESEARCH METHODOLOGY 1
1.2. RESEARCH SCOPE & ASSUMPTIONS 1
1.3. LIST OF DATA SOURCES 1


CHAP 2. EXECUTIVE SUMMARY 1
2.1. GLOBAL MEDICAL TOURISM MARKET SUMMARY & KEY BUYING CRITERIA 1
2.2. GLOBAL MEDICAL TOURISM MARKET OUTLOOK 1
2.3. MARKET SEGMENTATION ANALYSIS 1
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 1
2.5. GLOBAL MEDICAL TOURISM MARKET VALUE CHAIN ANALYSIS 1
2.6. VENDOR LANDSCAPE 1


CHAP 3. GLOBAL MEDICAL TOURISM MARKET 1
3.1. MARKET DRIVER ANALYSIS 1
3.1.1. AFFORDABLE GOOD QUALITY CARE 1
3.1.2. AVAILABILITY OF QUALITY CARE 1
3.1.3. ACCESSIBLE INFORMATION AND CARE 1
3.1.4. ASSISTANCE AND SUPPORT FROM GOVERNMENT AGENCIES AND ASSOCIATIONS 1
3.2. MARKET RESTRAINT ANALYSIS 1
3.2.1. LIMITED COVERAGE AND LENGTHY PARTIAL REIMBURSEMENT BY PAYERS 1
3.2.2. DIFFICULTIES ASSOCIATED WITH TRAVEL, LANGUAGE BARRIERS, AVAILABILITY, DOCUMENTATION, AND VISA APPROVAL ISSUES 1
3.3. KEY OPPORTUNITIES 1
3.3.1. OVERSEAS PROMOTIONAL OFFICES IS KEY SOURCES OF MEDICAL TOURISTS 1
3.3.2. WIDER HOSPITAL NETWORK UNDER INSURANCE COVERAGE FOR CASHLESS TRANSACTIONS 1
3.4. CHALLENGES 1
3.4.1. FOLLOW-UP CARE 1
3.4.2. MEDICAL MALPRACTICE 1


CHAP 4. INDUSTRY ANALYSIS 1
4.1. GLOBAL MEDICAL TOURISM MARKET– PORTER’S FIVE FORCE MODEL 1
4.2. GLOBAL MEDICAL TOURISM MARKET– PESTEL ANALYSIS 1
4.3. GLOBAL MEDICAL TOURISM MARKET– GAP ANALYSIS 1


CHAP 5. GLOBAL MEDICAL TOURISM MARKET BY TREATMENT TYPE 2012-2022 ($ MILLION) 1
5.1. GLOBAL MEDICAL TOURISM MARKET BY CARDIOVASCULAR TREATMENT 2012-2022 ($ MILLION) 1
5.2. GLOBAL MEDICAL TOURISM MARKET BY ORTHOPEDIC TREATMENT 2012-2022 ($ MILLION) 1
5.3. GLOBAL MEDICAL TOURISM MARKET BY NEUROLOGICAL TREATMENT 2012-2022 ($ MILLION) 1
5.4. GLOBAL MEDICAL TOURISM MARKET BY CANCER TREATMENT 2012-2022 ($ MILLION) 1
5.5. GLOBAL MEDICAL TOURISM MARKET BY FERTILITY TREATMENT 2012-2022 ($ MILLION) 1
5.6. GLOBAL MEDICAL TOURISM MARKET BY OTHER GENERAL TREATMENTS 2012-2022 ($ MILLION) 1


CHAP 6. GLOBAL MEDICAL TOURISM MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 1
6.1. GLOBAL MEDICAL TOURISM MARKET BY REGION 2012-2022 ($ MILLION) 1
6.2. NORTH AMERICA 1
6.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 1
6.2.3.1. U.S. 1
6.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.2.3.2. CANADA 1
6.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.2.3.3. MEXICO 1
6.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3. EUROPE 1
6.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 1
6.3.3.1. GERMANY 1
6.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3.3.2. UK 1
6.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3.3.3. FRANCE 1
6.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3.3.3.3. SPAIN 1
6.3.3.3.4. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.3.3.3.5. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3.3.3.6. ITALY 1
6.3.3.3.7. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.3.3.3.8. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.3.3.4. REST OF EUROPE 1
6.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 1
6.3.3.4.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.4. ASIA PACIFIC 1
6.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 1
6.4.3.1. CHINA 1
6.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.4.3.2. INDIA 1
6.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.4.3.3. JAPAN 1
6.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.4.3.4. AUSTRALIA 1
6.4.3.4.1. AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.4.3.4.2. AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.4.3.5. OTHERS 1
6.4.3.5.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 1
6.4.3.5.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.5. REST OF THE WORLD 1
6.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
6.5.3. SOUTH AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
6.5.4. SOUTH AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1


CHAP 7. COMPETITIVE LANDSCAPE 1
7.1. ADITYA BIRLA MEMORIAL HOSPITAL 1
7.1.1. COMPANY OVERVIEW 1
7.1.2. SCOT ANALYSIS 1
7.1.3. PRODUCT BENCHMARKING 1
7.1.4. STRATEGIC INITIATIVES 1
7.2. APOLLO HOSPITALS ENTERPRISE LIMITED 1
7.2.1. COMPANY OVERVIEW 1
7.2.2. SCOT ANALYSIS 1
7.2.3. PRODUCT BENCHMARKING 1
7.2.4. STRATEGIC INITIATIVES 1
7.3. ASIAN HEART INSTITUTE 1
7.3.1. COMPANY OVERVIEW 1
7.3.2. SCOT ANALYSIS 1
7.3.3. PRODUCT BENCHMARKING 1
7.3.4. STRATEGIC INITIATIVES 1
7.4. BARBADOS FERTILITY CENTRE 1
7.4.1. COMPANY OVERVIEW 1
7.4.2. SCOT ANALYSIS 1
7.4.3. PRODUCT BENCHMARKING 1
7.4.4. STRATEGIC INITIATIVES 1
7.5. BUMRUNGRAD INTERNATIONAL HOSPITAL 1
7.5.1. COMPANY OVERVIEW 1
7.5.2. SCOT ANALYSIS 1
7.5.3. PRODUCT BENCHMARKING 1
7.5.4. STRATEGIC INITIATIVES 1
7.6. FORTIS HEALTHCARE LIMITED 1
7.6.1. COMPANY OVERVIEW 1
7.6.2. SCOT ANALYSIS 1
7.6.3. PRODUCT BENCHMARKING 1
7.6.4. STRATEGIC INITIATIVES 1
7.7. INFECTIOUS DISEASES PARTNERS PTE LTD. 1
7.7.1. COMPANY OVERVIEW 1
7.7.2. SCOT ANALYSIS 1
7.7.3. PRODUCT BENCHMARKING 1
7.7.4. STRATEGIC INITIATIVES 1
7.8. KPJ HEALTHCARE BERHA 1
7.8.1. COMPANY OVERVIEW 1
7.8.2. SCOT ANALYSIS 1
7.8.3. PRODUCT BENCHMARKING 1
7.8.4. STRATEGIC INITIATIVES 1
7.9. MIN-SHENG GENERAL HOSPITAL 1
7.9.1. COMPANY OVERVIEW 1
7.9.2. SCOT ANALYSIS 1
7.9.3. PRODUCT BENCHMARKING 1
7.9.4. STRATEGIC INITIATIVES 1
7.10. NTT MEDICAL CENTER TOKYO 1
7.10.1. COMPANY OVERVIEW 1
7.10.2. SCOT ANALYSIS 1
7.10.3. PRODUCT BENCHMARKING 1
7.10.4. STRATEGIC INITIATIVES 1
7.11. PRINCE COURT MEDICAL CENTRE 1
7.11.1. COMPANY OVERVIEW 1
7.11.2. SCOT ANALYSIS 1
7.11.3. PRODUCT BENCHMARKING 1
7.11.4. STRATEGIC INITIATIVES 1
7.12. RAFFLES MEDICAL GROUP 1
7.12.1. COMPANY OVERVIEW 1
7.12.2. SCOT ANALYSIS 1
7.12.3. PRODUCT BENCHMARKING 1
7.12.4. STRATEGIC INITIATIVES 1
7.13. SAMITIVEJ PUBLIC COMPANY LIMITED 1
7.13.1. COMPANY OVERVIEW 1
7.13.2. SCOT ANALYSIS 1
7.13.3. PRODUCT BENCHMARKING 1
7.13.4. STRATEGIC INITIATIVES 1
7.14. SEOUL NATIONAL UNIVERSITY HOSPITAL 1
7.14.1. COMPANY OVERVIEW 1
7.14.2. SCOT ANALYSIS 1
7.14.3. PRODUCT BENCHMARKING 1
7.14.4. STRATEGIC INITIATIVES 1
7.15. UZ LEUVEN (UNIVERSITY HOSPITALS LEUVEN) 1
7.15.1. COMPANY OVERVIEW 1
7.15.2. SCOT ANALYSIS 1
7.15.3. PRODUCT BENCHMARKING 1
7.15.4. STRATEGIC INITIATIVES 1

TABLE 1 GLOBAL MEDICAL TOURISM MARKET BY TREATMENT TYPE 2012-2022 ($ MILLION) 1
TABLE 2 GLOBAL MEDICAL TOURISM MARKET BY CARDIOVASCULAR TREATMENT 2012-2022 ($ MILLION) 1
TABLE 3 GLOBAL MEDICAL TOURISM MARKET BY ORTHOPEDIC TREATMENT 2012-2022 ($ MILLION) 1
TABLE 4 GLOBAL MEDICAL TOURISM MARKET BY NEUROLOGICAL TREATMENT 2012-2022 ($ MILLION) 1
TABLE 5 GLOBAL MEDICAL TOURISM MARKET BY CANCER TREATMENT 2012-2022 ($ MILLION) 1
TABLE 6 GLOBAL MEDICAL TOURISM MARKET BY FERTILITY TREATMENT 2012-2022 ($ MILLION) 1
TABLE 7 GLOBAL MEDICAL TOURISM MARKET BY OTHER GENERAL TREATMENTS 2012-2022 ($ MILLION) 1
TABLE 8 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 9 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 10 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 1
TABLE 11 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 12 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 13 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 14 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 15 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 16 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 17 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 18 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 19 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 1
TABLE 20 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 21 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 22 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 23 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 24 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 25 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 26 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 27 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 28 ITALY MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 1
TABLE 29 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 30 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 31 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 32 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 33 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 1
TABLE 34 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 35 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 36 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 37 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 38 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 39 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 40 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 41 AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 42 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 1
TABLE 43 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 44 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
TABLE 45 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1
TABLE 46 SOUTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 1

FIGURE 1 MARKET SHARE BY REGION 1
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 10 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 11 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 15 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 16 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 17 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1
FIGURE 18 SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 1

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)